Curia is a business services company based in the United States, specializing in research and development within the biotech and pharmaceutical sectors. Founded in 1991, the company employs between 1,001 and 5,000 individuals and generates significant revenue, reflecting its established presence in the industry. Curia's expertise encompasses life sciences manufacturing, with a focus on small molecule Active Pharmaceutical Ingredients (APIs) and biopharmaceutical manufacturing. A recent white paper published by the company discusses the evolution of small molecule API production, highlighting the growing relevance of fermentation techniques that blend traditional chemical synthesis with advancements in synthetic biology. The document outlines Curia's capabilities in both upstream and downstream processes, including cell bank construction, strain improvement, fermentation development, and process scale-up. The company emphasizes the sustainability and flexibility of fermentation processes, which allow for the creation of novel molecular structures and the production of a wide variety of compounds, including pharmaceutical intermediates and agricultural products.